127 related articles for article (PubMed ID: 8845835)
1. Predominance of null mutations in ataxia-telangiectasia.
Gilad S; Khosravi R; Shkedy D; Uziel T; Ziv Y; Savitsky K; Rotman G; Smith S; Chessa L; Jorgensen TJ; Harnik R; Frydman M; Sanal O; Portnoi S; Goldwicz Z; Jaspers NG; Gatti RA; Lenoir G; Lavin MF; Tatsumi K; Wegner RD; Shiloh Y; Bar-Shira A
Hum Mol Genet; 1996 Apr; 5(4):433-9. PubMed ID: 8845835
[TBL] [Abstract][Full Text] [Related]
2. Characterization of ATM gene mutations in 66 ataxia telangiectasia families.
Sandoval N; Platzer M; Rosenthal A; Dörk T; Bendix R; Skawran B; Stuhrmann M; Wegner RD; Sperling K; Banin S; Shiloh Y; Baumer A; Bernthaler U; Sennefelder H; Brohm M; Weber BH; Schindler D
Hum Mol Genet; 1999 Jan; 8(1):69-79. PubMed ID: 9887333
[TBL] [Abstract][Full Text] [Related]
3. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer.
Stankovic T; Kidd AM; Sutcliffe A; McGuire GM; Robinson P; Weber P; Bedenham T; Bradwell AR; Easton DF; Lennox GG; Haites N; Byrd PJ; Taylor AM
Am J Hum Genet; 1998 Feb; 62(2):334-45. PubMed ID: 9463314
[TBL] [Abstract][Full Text] [Related]
4. Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations.
Telatar M; Teraoka S; Wang Z; Chun HH; Liang T; Castellvi-Bel S; Udar N; Borresen-Dale AL; Chessa L; Bernatowska-Matuszkiewicz E; Porras O; Watanabe M; Junker A; Concannon P; Gatti RA
Am J Hum Genet; 1998 Jan; 62(1):86-97. PubMed ID: 9443866
[TBL] [Abstract][Full Text] [Related]
5. Accelerated replicative senescence of ataxia-telangiectasia skin fibroblasts is retained at physiologic oxygen levels, with unique and common transcriptional patterns.
Haj M; Levon A; Frey Y; Hourvitz N; Campisi J; Tzfati Y; Elkon R; Ziv Y; Shiloh Y
Aging Cell; 2023 Aug; 22(8):e13869. PubMed ID: 37254625
[TBL] [Abstract][Full Text] [Related]
6. Live-cell tracking of γ-H2AX kinetics reveals the distinct modes of ATM and DNA-PK in the immediate response to DNA damage.
Trakarnphornsombat W; Kimura H
J Cell Sci; 2023 Apr; 136(8):. PubMed ID: 36999484
[TBL] [Abstract][Full Text] [Related]
7. Analyses of canine cancer mutations and treatment outcomes using real-world clinico-genomics data of 2119 dogs.
Wu K; Rodrigues L; Post G; Harvey G; White M; Miller A; Lambert L; Lewis B; Lopes C; Zou J
NPJ Precis Oncol; 2023 Jan; 7(1):8. PubMed ID: 36658200
[TBL] [Abstract][Full Text] [Related]
8. Cancer and Radiosensitivity Syndromes: Is Impaired Nuclear ATM Kinase Activity the Primum Movens?
El Nachef L; Berthel E; Ferlazzo ML; Le Reun E; Al-Choboq J; Restier-Verlet J; Granzotto A; Sonzogni L; Bourguignon M; Foray N
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551628
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Clinical and Genetic Characterization of Three Ataxia-Telangiectasia Pedigrees With Novel
Huang P; Zhang L; Tang L; Ren Y; Peng H; Xiong J; Liu L; Xu J; Xiao Y; Li J; Mao D; Liu L
Front Pediatr; 2022; 10():877826. PubMed ID: 35586824
[TBL] [Abstract][Full Text] [Related]
10. Unusual clinical manifestations and predominant stopgain ATM gene variants in a single centre cohort of ataxia telangiectasia from North India.
Rawat A; Tyagi R; Chaudhary H; Pandiarajan V; Jindal AK; Suri D; Gupta A; Sharma M; Arora K; Bal A; Madaan P; Saini L; Sahu JK; Ogura Y; Kato T; Imai K; Nonoyama S; Singh S
Sci Rep; 2022 Mar; 12(1):4036. PubMed ID: 35260754
[TBL] [Abstract][Full Text] [Related]
11. Persistent DNA damage associated with ATM kinase deficiency promotes microglial dysfunction.
Bourseguin J; Cheng W; Talbot E; Hardy L; Lai J; Jeffries AM; Lodato MA; Lee EA; Khoronenkova SV
Nucleic Acids Res; 2022 Mar; 50(5):2700-2718. PubMed ID: 35212385
[TBL] [Abstract][Full Text] [Related]
12. ATM Kinase Dead: From Ataxia Telangiectasia Syndrome to Cancer.
Putti S; Giovinazzo A; Merolle M; Falchetti ML; Pellegrini M
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771661
[TBL] [Abstract][Full Text] [Related]
13. A novel, ataxic mouse model of ataxia telangiectasia caused by a clinically relevant nonsense mutation.
Perez H; Abdallah MF; Chavira JI; Norris AS; Egeland MT; Vo KL; Buechsenschuetz CL; Sanghez V; Kim JL; Pind M; Nakamura K; Hicks GG; Gatti RA; Madrenas J; Iacovino M; McKinnon PJ; Mathews PJ
Elife; 2021 Nov; 10():. PubMed ID: 34723800
[TBL] [Abstract][Full Text] [Related]
14. Analyzing the Opportunities to Target DNA Double-Strand Breaks Repair and Replicative Stress Responses to Improve Therapeutic Index of Colorectal Cancer.
Tomasini PP; Guecheva TN; Leguisamo NM; Péricart S; Brunac AC; Hoffmann JS; Saffi J
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34201502
[TBL] [Abstract][Full Text] [Related]
15. The Cancer-Associated ATM R3008H Mutation Reveals the Link between ATM Activation and Its Exchange.
Milanovic M; Houghton LM; Menolfi D; Lee JH; Yamamoto K; Li Y; Lee BJ; Xu J; Estes VM; Wang D; Mckinnon PJ; Paull TT; Zha S
Cancer Res; 2021 Jan; 81(2):426-437. PubMed ID: 33239428
[TBL] [Abstract][Full Text] [Related]
16. Expanding the genotype-phenotype correlation of childhood sensory polyneuropathy of genetic origin.
Chakravorty S; Logan R; Elson MJ; Luke RR; Verma S
Sci Rep; 2020 Sep; 10(1):16184. PubMed ID: 32999401
[TBL] [Abstract][Full Text] [Related]
17. ATM-Deficient Cancers Provide New Opportunities for Precision Oncology.
Jette NR; Kumar M; Radhamani S; Arthur G; Goutam S; Yip S; Kolinsky M; Williams GJ; Bose P; Lees-Miller SP
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32183301
[TBL] [Abstract][Full Text] [Related]
18. Childhood-onset autosomal recessive ataxias: a cross-sectional study from Turkey.
Mutlu-Albayrak H; Kırat E; Gürbüz G
Neurogenetics; 2020 Jan; 21(1):59-66. PubMed ID: 31741144
[TBL] [Abstract][Full Text] [Related]
19. Ataxia-telangiectasia-like disorder in a family deficient for MRE11A, caused by a
Sedghi M; Salari M; Moslemi AR; Kariminejad A; Davis M; Goullée H; Olsson B; Laing N; Tajsharghi H
Neurol Genet; 2018 Dec; 4(6):e295. PubMed ID: 30584599
[TBL] [Abstract][Full Text] [Related]
20. pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry.
Jones GN; Rooney C; Griffin N; Roudier M; Young LA; Garcia-Trinidad A; Hughes GD; Whiteaker JR; Wilson Z; Odedra R; Zhao L; Ivey RG; Howat WJ; Harrington EA; Barrett JC; Ramos-Montoya A; Lau A; Paulovich AG; Cadogan EB; Pierce AJ
Br J Cancer; 2018 Nov; 119(10):1233-1243. PubMed ID: 30385821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
